These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9467135)

  • 21. [Occult diabetes insipidus of a pitressin-resistant and familial type in infants. Presentation of a case].
    Gandullia E; Lignana E
    Minerva Pediatr; 1979 Mar; 31(6):429-34. PubMed ID: 470886
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of exogenous 3':5'-adenosine monophosphate on urinary output in children with vasopressin-resistant diabetes insipidus.
    Proesmans W; Eggermont E; Vanderschueren-Lodeweyckx M; Tiddens H; Eeckels R
    Pediatr Res; 1975 May; 9(5):509-12. PubMed ID: 166349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient diabetes insipidus in critically ill COVID19 patients.
    Statlender L; Fishman G; Hellerman M; Kagan I; Bendavid I; Gorfil D; Kaptzon S; Singer P
    J Crit Care; 2023 Apr; 74():154211. PubMed ID: 36630859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of the response to vasopressin (pitressin) by treatment with a combination of chlorpropamide and chlorothiazide in Brattleboro rats with hereditary hypothalamic diabetes insipidus.
    Laycock JF; Lewis AF
    Br J Pharmacol; 1977 Jan; 59(1):11-6. PubMed ID: 836992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commentary: On the use of pitressin in infants with neurogenic diabetes insipidue.
    Crigler JF
    J Pediatr; 1976 Feb; 88(2):295-6. PubMed ID: 1249693
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyponatremia in the postoperative craniofacial pediatric patient population: a connection to cerebral salt wasting syndrome and management of the disorder.
    Levine JP; Stelnicki E; Weiner HL; Bradley JP; McCarthy JG
    Plast Reconstr Surg; 2001 Nov; 108(6):1501-8. PubMed ID: 11711918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical characteristics of 7 patients with gestational diabetes insipidus].
    Wu LQ; Xiong CQ; Wu M; Dong RL; Chen YQ; Gao J; Chen OJ; Huang YP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):266-8. PubMed ID: 18843966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diuretic and antidiuretic effects of furosemide before and during the early period of pitressin therapy in diabetes insipidus.
    Radó JP; Takó J; Szabó T; Bános C
    Endokrinologie; 1969; 54(1):26-35. PubMed ID: 5358572
    [No Abstract]   [Full Text] [Related]  

  • 29. Antidiuretic responses to hypertonic saline infusion, water deprivation, and a synthetic analogue of vasopressin in patients with hereditary, hypothalamic diabetes insipidus.
    Andersson KE; Arner B; Fürst E; Hedner P
    Acta Med Scand; 1974; 195(1-2):17-23. PubMed ID: 4817085
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diabetes insipidus (classification, diagnosis, therapy)].
    Uhlich E; Buchborn E
    Internist (Berl); 1972 Apr; 13(4):141-7. PubMed ID: 4555566
    [No Abstract]   [Full Text] [Related]  

  • 31. Diabetes insipidus in severely brain damaged children.
    Barzilay Z; Somekh E
    J Med; 1988; 19(1):47-64. PubMed ID: 3221143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes insipidus as a complication after pituitary surgery.
    Loh JA; Verbalis JG
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):489-94. PubMed ID: 17515893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple diagnosis of diabetes insipidus and antidiuretic hormone excess.
    Kovács L; Némethova V; Gucalová Y; Lehotská V; Cintala J; Michajlovskij N; Michalicková J; Lichardus B
    Exp Clin Endocrinol; 1985 Apr; 85(2):228-34. PubMed ID: 4018160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of diabetes insipidus by the buccal administration of posterior pituitary powder (pitressin).
    KLEIN R; LARON Z
    J Clin Endocrinol Metab; 1957 Mar; 17(3):445-8. PubMed ID: 13406006
    [No Abstract]   [Full Text] [Related]  

  • 35. Pitressin toxicity in diabetes insipidus, and the therapeutic superiority of the nasal route for replacement therapy; report of a case.
    SMITH WW
    Ohio State Med J; 1957 Nov; 53(11):1277-9. PubMed ID: 13477644
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies.
    Edwards CR; Kitau MJ; Chard T; Besser GM
    Br Med J; 1973 Aug; 3(5876):375-8. PubMed ID: 4581079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes insipidus in infancy resistant to pitressin.
    KAO YUN-CHEN ; STEINER MM
    Pediatrics; 1953 Oct; 12(4):400-10. PubMed ID: 13099911
    [No Abstract]   [Full Text] [Related]  

  • 38. Hereditary pitressin-resistant diabetes insipidus.
    CARRE IJ; McCOY JE
    Acta Paediatr (Stockh); 1959 May; 48(3):223-32. PubMed ID: 13649344
    [No Abstract]   [Full Text] [Related]  

  • 39. Patterns of anti-diuretic function in diabetes insipidus caused by histiocytosis X.
    Helbock H; Krivit W; Nesbit ME
    J Lab Clin Med; 1971 Aug; 78(2):194-202. PubMed ID: 5567562
    [No Abstract]   [Full Text] [Related]  

  • 40. Free water excess is not the main cause for hyponatremia in critically ill children receiving conventional maintenance fluids.
    Singhi S; Jayashre M
    Indian Pediatr; 2009 Jul; 46(7):577-83. PubMed ID: 19430087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.